Eli Lilly and Company

Eli Lilly and Company

Eli Lilly and Company

Latest investments Show all
$31,000,000
Venture capital (Series A)
Magnolia Neurosciences
Undisclosed funding
Sigilon Therapeutics
Team Size
1–10
Employees
Past year's investments

Eli Lilly and Company participated in fewer than 3 rounds over the past year

Latest rounds
  • Magnolia Neurosciences: Venture capital (Series A) ($31M)
  • Sigilon Therapeutics: Undisclosed funding (Undisclosed amount)
  • Petra Pharma: Venture capital (Series A) ($48M)